September 28, 2020
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
March 8, 2019
AMAG Pharmaceuticals (NASDAQ:AMAG) has announced topline results from its PROLONG trial evaluating Makena in patients with a history of a...
September 26, 2018
AMAG Pharmaceuticals (NASDAQ:AMAG) today announced it has acquired global rights to develop and market digoxin immune Fab (ovine) (DIF), a polyclonal...
April 29, 2018
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 1, 2018
Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.
March 26, 2018
AMAG Pharmaceuticals (NASDAQ:AMAG) announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration...
March 18, 2018
Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...